Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyskinesia, Drug-Induced”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Post-approval studies (Phase 4)Study completedNCT05859698
What this trial is testing

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 59
Not applicableLooking for participantsNCT07173920
What this trial is testing

Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD

Who this might be right for
Tardive DyskinesiaRepetitive Transcranial Magnetic Stimulation
Peking University Sixth Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT06731868
What this trial is testing

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Luye Pharma Group Ltd. 120
Large-scale testing (Phase 3)Study completedNCT02195700
What this trial is testing

Aim to Reduce Movements in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 117
Large-scale testing (Phase 3)Study completedNCT02291861
What this trial is testing

Addressing Involuntary Movements in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 298
Not applicableUnknownNCT01804920
What this trial is testing

D-Serine Treatment For Tardive Dyskinesia

Who this might be right for
Schizophrenia and Schizoaffective DisorderTardive Dyskinesia
Herzog Hospital 16
Large-scale testing (Phase 3)Study completedNCT02198794
What this trial is testing

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 343
Large-scale testing (Phase 3)Study completedNCT02274558
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 234
Testing effectiveness (Phase 2)Study completedNCT01173731
What this trial is testing

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedLevodopa
Novartis Pharmaceuticals 66
Large-scale testing (Phase 3)WithdrawnNCT01908452
What this trial is testing

Pyridoxal Kinase Activity in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center
Post-approval studies (Phase 4)Study completedNCT00621998
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-Induced Tardive Dyskinesia
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Early research (Phase 1)WithdrawnNCT05053321
What this trial is testing

Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine

Who this might be right for
Tardive Dyskinesia
Yale University
Not applicableNot Yet RecruitingNCT06218719
What this trial is testing

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Who this might be right for
Tardive Dyskinesia
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Study completedNCT01393600
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 37
Testing effectiveness (Phase 2)WithdrawnNCT02064010
What this trial is testing

Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

Who this might be right for
Drug-induced Tardive Dyskinesia
Synchroneuron Inc.
Not applicableStudy completedNCT00065286
What this trial is testing

Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation

Who this might be right for
Akathisia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Testing effectiveness (Phase 2)Ended earlyNCT00693472
What this trial is testing

Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

Who this might be right for
Akathisia, Drug-InducedAntipsychotic AgentsMovement Disorders
Merck Sharp & Dohme LLC 46
Post-approval studies (Phase 4)Not Yet RecruitingNCT06997198
What this trial is testing

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
University Hospitals Cleveland Medical Center 25
Not applicableUnknownNCT02840760
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.

Who this might be right for
Tardive Dyskinesia
Shanghai Mental Health Center 60
Load More Results